NCT00132821View on ClinicalTrials.gov

Impact of Smoking Cessation on Sleep - 5

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Tobacco Use CessationSleep Disorders
Interventions
DRUG

Bupropion

Days 1-3, 150 mg Bupropion in am; days 4-63, 300 mg Bupropion (150 mg in am and 150 mg in pm)

DRUG

Transdermal Nicotine Patch

21-mg nicotine patch applied in AM for 6 weeks, starting on the morning of quit day; 14-mg patch applied in AM for 2 weeks; 7-mg patch applied in AM for 1 week

DRUG

Placebo Bupropion

Days 1-3, 150 mg placebo Bupropion in am; days 4-63, 300 mg placebo Bupropion (150 mg in am and 150 mg in pm)

DRUG

Placebo transdermal nicotine patch

21-mg placebo nicotine patch applied in AM for 6 weeks, starting on the morning of quit day; 14-mg placebo patch applied in AM for 2 weeks; 7-mg placebo patch applied in AM for 1 week

Trial Locations (1)

94025

SRI International, Menlo Park

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00132821 - Impact of Smoking Cessation on Sleep - 5 | Biotech Hunter | Biotech Hunter